Teknova expedites clinical breakthroughs by allowing scientists to focus on discovery, product development, and production. An established leader in custom manufacturing for the life science, biopharma, and healthcare industries, Teknova provides critical reagents for bioprocessing, bioproduction, and molecular diagnostics. Product offerings include cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents.
Priding itself on its agility and customer centricity, Teknova meets the most complex formulation and packaging requirements and delivers with unrivalled speed. The company supports research, clinical, and applied markets with catalog and custom products, delivering cost savings for research, development, and production of diagnostics, vaccines, and therapeutics. All products are manufactured in facilities that are ISO 13485:2016 certified, US FDA 21 CPR Part 820 compliant, and FDA registered.
As a partner to the biopharma sector, Teknova provides end-to-end solutions in the development of reagents and processes for a multitude of established and emerging applications, including vaccine production and gene therapy. The company’s R&D team offers expertise from prototype product design to guidance on GMP manufacturing of media, buffers, and reagents for the entire gene therapy workflow.
Teknova was founded in 1996 by Ted Davis, a Genentech scientist, who identified the need for custom media and buffers manufactured to the same quality standards as commercially available, inventoried solutions. The company headquarters and research services facility are located near the San Francisco Bay Area in Hollister, CA, USA, with additional facilities in Mansfield, MA, USA.